Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Express Scripts Earnings Surged 74%; Forecast Clears Lowered Hurdle

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/18/2013 | 11:18pm CEST
   By Jon Kamp 
 

Pharmacy-benefit manager Express Scripts Holding Co. (>> Express Scripts Holding Co) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 earnings mostly ahead of a Wall Street target the company helped drag lower three months ago.

The St. Louis-based company--which manages drug-benefit programs for health plans and corporate customers--rattled analysts in November when it said their forecasts for 2013 looked too high. Express Scripts didn't release its own guidance at the time, but said a still-weak economy was weighing on the number of prescriptions it handles.

Monday's release finally included company guidance for adjusted earnings of $4.20 to $4.30 per share this year. The target is largely above the $4.20 forecast among analysts surveyed by Thomson Reuters, although Express Scripts' November warning caused analysts to trim the consensus forecast by about 30 cents since then.

This will mark the first full year of combined operations for Express Scripts and Medco Health Solutions, which created the largest pharmacy-benefit manager, or PBM, following April's $29.1 billion Medco acquisition.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," George Paz, Express Scripts' chief executive, said in a press release.

The company plans to hold a conference call Tuesday morning. Its shares are up about 2.9% so far this year, through Friday's close, trailing a 6.6% gain in the Standard & Poor's 500 index.

The company reported fourth-quarter earnings of $504.1 million, or 61 cents a share, up from $290.4 million, or 59 cents a share, a year earlier. Excluding deal-related costs and other items, per-share earnings rose to $1.05 from 82 cents.

Revenue more than doubled to $27.41 billion from the year-earlier period, which was before the Medco deal.

Analysts surveyed by Thomson Reuters had forecast earnings of $1.04 a share on sales of $27.24 billion. Analysts are forecasting lower sales in coming quarters as health insurer UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) brings in-house the PBM business it had outsourced to Medco.

Express Scripts saw adjusted claims--a measure that takes into account monthly prescriptions filled in retail pharmacies and 90-day fills through the company's mail-order business--rise 111% in the recent quarter to 410.8 million.

The company's full-year adjusted claims tally about matched its target by nearing 1.4 billion. The company expects 5% to 7% growth in adjusted claims this year.

Its adjusted earnings forecast represents 12% to 15% growth.

Write to Jon Kamp at jon.kamp@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Express Scripts Holding Co, UnitedHealth Group Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
07/20 EXPRESS SCRIPTS : Senator balks at Greitens' drug monitoring plan over campaign ..
07/18 EXPRESS SCRIPTS : Governor signs order for drug monitoring
07/17 EXPRESS SCRIPTS : Greitens launches painkiller database after Missouri lawmakers..
07/17 EXPRESS SCRIPTS : Missouri becomes last state to create drug-monitoring plan
07/06 Express Scripts Holding Company Announces Second Quarter 2017 Earnings Confer..
06/30 EXPRESS SCRIPTS : BioSTL brings international health care execs to St. Louis for..
06/29 EXPRESS SCRIPTS : BESt pharmacy program celebrates 10th anniversary
06/27 EXPRESS SCRIPTS HOLDING COMPANY (NAS : ESRX) Files An 8-K Departure of Directors..
06/27 EXPRESS SCRIPTS HOLDING CO. : Change in Directors or Principal Officers (form 8-..
06/27 EXPRESS SCRIPTS : Elects Kathleen M. Mazzarella to Board of Directors
More news
News from SeekingAlpha
07/13 Hold On To Starbucks - Cramer's Lightning Round (7/12/17)
07/12 Express Scripts Looks Undervalued In A Very Hot Sector
07/06 McKesson Is Unquestionably Undervalued
07/04 July 'Old Reliables'
06/16 ANTHEM : Will The Yield Rebound With Cigna Gone?
Financials ($)
Sales 2017 101 585 M
EBIT 2017 7 031 M
Net income 2017 3 088 M
Debt 2017 11 283 M
Yield 2017 -
P/E ratio 2017 11,73
P/E ratio 2018 10,45
EV / Sales 2017 0,48x
EV / Sales 2018 0,45x
Capitalization 37 249 M
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Technical analysis trends EXPRESS SCRIPTS HOLDING CO
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 65,8 $
Spread / Average Target 6,0%
EPS Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Chief Operating Officer & Executive Vice President
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDING CO-9.80%37 249
WALGREENS BOOTS ALLIANCE-3.87%85 137
CVS HEALTH-1.93%78 845
MCKESSON CORPORATION17.37%34 859
CARDINAL HEALTH INC6.99%24 323
AMERISOURCEBERGEN CORP.16.86%19 908